For Generics, EU Reference Product Is Non-Negotiable – Even In Pilot On Parallel Advice
Executive Summary
Acknowledging that it may be a barrier to some extent, EMA’s senior scientific specialist of clinical pharmacology Kevin Blake notes that EU reference medicinal products are a legal requirement for bioequivalence studies and cannot be circumvented.